RI
PYXS icon

RTW Investments’s Pyxis Oncology PYXS Stock Holding History

RTW Investments’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-682,220
Closed -$1.62M – 96
2022
Q2 		$1.62M Sell
682,220
-1,438,540
-68% -$3.83M 0.04% 97
2022
Q1 		$8.57M Hold
2,120,760
– – 0.18% 68
2021
Q4 		$23.3M Buy
+2,120,760
New +$24.3M 0.34% 64

Other funds holding PYXS

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

RTW Investments's PYXS Position: Q3 2022 in Review

RTW Investments sold out of Pyxis Oncology (PYXS) in Q3 2022, closing a stake of 682,220 shares — an estimated $1.62M sold.

RTW Investments first reported a position in PYXS in Q4 2021 and held it in 3 quarters. The position peaked at $23.3M in Q4 2021. 38 funds tracked by Wall St. Rank hold PYXS as of Q3 2022.

  • RTW Investments reported no remaining Pyxis Oncology position as of Q3 2022 after selling out during the quarter.
  • RTW Investments sold 682,220 Pyxis Oncology shares in Q3 2022, an estimated $1.62M.
  • RTW Investments first reported a position in Pyxis Oncology in Q4 2021 and held it in 3 quarters.
  • RTW Investments's Pyxis Oncology position peaked at $23.3M in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.